Not recruiting
COVID-19
Not recruitingInvestigationalNo placebo
Study of GS-5245 for Treating COVID-19 in Children and Adolescents
InvestigationalNo placebo
Countries:
Spain
Spain- Participants:0–17 years
- Substances:Gs-5245
Find therapies in clinical trials near you – page 26
- recruiting
- 3 961
- countries
- 28
- conditions
- 2 103
3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today
329 trials match your criteria
Not recruiting
Type 1 diabetes mellitus
Not recruitingRegistered drug
Study on Frexalimab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients Aged 12-21 on Insulin Therapy
Registered drug
- Disease:Type 1 diabetes mellitus
- Substances:–
Countries:Spain
Spain- Participants:0–17 years · 18–64 years
Not recruiting
Tuberous sclerosis complex+1
Not recruitingInvestigationalNo placebo
Study on Radiprodil for Seizures and Behavioral Symptoms in Patients with Tuberous Sclerosis Complex or Focal Cortical Dysplasia Type II
InvestigationalNo placebo
- Disease:Tuberous sclerosis complexCortical dysplasia
- Substances:Radiprodil
Countries:Spain
Spain- Participants:0–17 years
- Substances:Radiprodil
Not recruiting
Juvenile idiopathic arthritis
Not recruitingRegistered drugNo placebo
Study on Filgotinib for Children and Teens with Juvenile Idiopathic Arthritis
Registered drugNo placebo
- Disease:Juvenile idiopathic arthritis
- Substances:Filgotinib
Countries:Spain
Spain- Participants:0–17 years
- Substances:Filgotinib
Not recruiting
Factor VIII deficiency
Not recruitingInvestigationalNo placebo
Study on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months
InvestigationalNo placebo
- Disease:Factor VIII deficiency
- Substances:Efanesoctocog Alfa
Countries:Spain
Spain- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Efanesoctocog Alfa
Not recruiting
InvestigationalNo placebo
Study on the Safety and Immune Response of GSK's Herpes Zoster Vaccine in Immunocompromised Children Aged 1-17 with Kidney Transplants
InvestigationalNo placebo
- Substances:Gskvx000000014593
Countries:Spain
Spain- Participants:0–17 years
- Substances:Gskvx000000014593
Not recruiting
Pulmonary arterial hypertension
Not recruitingRegistered drug
Study on Selexipag and Bosentan for Children with Pulmonary Arterial Hypertension
Registered drug
- Disease:Pulmonary arterial hypertension
- Substances:BosentanSelexipag
Countries:Spain
Spain- Participants:0–17 years
- Substances:Bosentan
Not recruiting
Pneumonia
Not recruitingRegistered drugNo placebo
Study on the Safety of Ceftolozane and Tazobactam for Children with Hospital-Acquired Pneumonia
Registered drugNo placebo
- Disease:Pneumonia
- Substances:CeftolozaneTazobactam
Countries:Spain
Spain- Participants:0–17 years
- Substances:Ceftolozane
Not recruiting
Asthma
Not recruitingRegistered drug
Study on the Effectiveness and Safety of Benralizumab for Children with Severe Eosinophilic Asthma
Registered drug
- Disease:Asthma
- Substances:Benralizumab
Countries:Spain
Spain- Participants:0–17 years
- Substances:Benralizumab
Not recruiting
Netherton's syndrome
Not recruitingInvestigational
Study to Evaluate the Effectiveness of Spesolimab in Treating Patients with Netherton Syndrome
Investigational
- Disease:Netherton's syndrome
- Substances:Spesolimab
Countries:Spain
Spain- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Spesolimab
Not recruiting
Epilepsy
Not recruitingInvestigationalNo placebo
Study on Ganaxolone for Children and Adults with Epilepsy Related to Tuberous Sclerosis Complex
InvestigationalNo placebo
- Disease:Epilepsy
- Substances:Ganaxolone
Countries:Spain
Spain- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Ganaxolone
Not recruiting
Anal fistula+1
Not recruitingRegistered drugNo placebo
Study on the Effectiveness and Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for Treating Complex Perianal Fistulas in Children with Crohn's Disease
Registered drugNo placebo
- Disease:Anal fistulaCrohn's disease
- Substances:Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Expanded
Countries:Spain
Spain- Participants:0–17 years
- Substances:Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Expanded